![Mark D. Perrin](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Mark D. Perrin
Keine laufenden Positionen mehr
Karriereverlauf von Mark D. Perrin
Ehemalige bekannte Positionen von Mark D. Perrin
Unternehmen | Position | Beginn | Ende |
---|---|---|---|
INVIVO THERAPEUTICS HOLDINGS CORP. | Direktor/Vorstandsmitglied | 06.01.2014 | 06.02.2015 |
Vorstandsvorsitzender | 06.01.2014 | 18.12.2017 | |
Vorsitzender | 06.02.2015 | 18.12.2017 | |
Dennan Consulting | Präsident | - | 01.01.2014 |
ConjuChem Biotechnologies, Inc. /Old/
![]() ConjuChem Biotechnologies, Inc. /Old/ Pharmaceuticals: MajorHealth Technology ConjuChem Biotechnologies, Inc. develops peptide based pharmaceuticals to treat diseases such as congestive heart failure, diabetes, HIV/AIDS and human growth deficiencies. The company is a research and development company that develops technology that binds peptides to albumin in order to extend the half life of drugs from minutes to days. ConjuChem Biotechnologies is headquartered in Montréal , Canada. | Präsident | 10.10.2005 | 31.08.2009 |
Orphan Medical, Inc.
![]() Orphan Medical, Inc. Pharmaceuticals: MajorHealth Technology Orphan Medical, Inc. develops and markets pharmaceutical and health care products. The company was founded in 1993 and is located in Minnetonka, MN. | Corporate Officer/Principal | 01.01.2002 | 01.01.2005 |
COR Therapeutics, Inc.
![]() COR Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology COR Therapeutics, Inc.. The principal activities of the Company are the discovery, development and commercialization of novel pharmaceutical products to establish new standards of care for the treatment and prevention of severe cardiovascular diseases. Integrilin was the Company's first product taken from discovery to commercialization. A drug was approved to treat patients who undergo a procedure known as angioplasty to open blood vessels. This drug has also been approved to treat patients with intermittent chest pains known as unstable angina and patients suffering from a kind of Heart attack known as non-Q-wave myocardial infraction | Corporate Officer/Principal | 01.01.1995 | 01.01.2001 |
InVivo Therapeutics Corp.
![]() InVivo Therapeutics Corp. BiotechnologyHealth Technology InVivo Therapeutics Corp. operates as a medical device company that develops groundbreaking technologies for the treatment of spinal cord injuries. The company was founded by Joseph P. Vacanti and Robert S. Langer, Jr. in 2005 and is headquartered in Cambridge, MA. | Vorstandsvorsitzender | - | - |
Vorsitzender | - | - | |
ConjuChem Biotechnologies, Inc.
![]() ConjuChem Biotechnologies, Inc. Pharmaceuticals: MajorHealth Technology ConjuChem Biotechnologies, Inc. develops peptide based pharmaceuticals. Its peptide products are used to treat diseases such as congestive heart failure, diabetes, HIV/AIDS and human growth deficiencies. ConjuChem Biotechnologies is a research and development company that develops technology that binds peptides to albumin in order to extend the half life of drugs from minutes to days. The company was founded on August 25, 2009 and is headquartered in Montréal, Canada. | Vorstandsvorsitzender | 31.08.2009 | - |
Public Communications Contact | 13.01.2010 | - | |
Präsident | 31.08.2009 | - | |
Burroughs Wellcome | Vertrieb & Marketing | 01.01.1992 | - |
Lederle Laboratories
![]() Lederle Laboratories Miscellaneous Commercial ServicesCommercial Services Part of Pfizer Inc., Lederle Laboratories is a company that provides testing services. The company is based in Pearl River, NY. | Corporate Officer/Principal | 01.01.1979 | - |
Ausbildung von Mark D. Perrin
Fordham University | Undergraduate Degree |
Kellogg School of Management | Masters Business Admin |
Statistik
International
Vereinigte Staaten | 9 |
Kanada | 3 |
Vereinigtes Königreich | 2 |
Operativ
President | 3 |
Corporate Officer/Principal | 3 |
Chief Executive Officer | 3 |
Sektoral
Health Technology | 7 |
Consumer Services | 3 |
Commercial Services | 2 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
Börsennotierte Unternehmen | 1 |
---|---|
INVIVO THERAPEUTICS HOLDINGS CORP. | Health Technology |
Private Unternehmen | 8 |
---|---|
ConjuChem Biotechnologies, Inc. /Old/
![]() ConjuChem Biotechnologies, Inc. /Old/ Pharmaceuticals: MajorHealth Technology ConjuChem Biotechnologies, Inc. develops peptide based pharmaceuticals to treat diseases such as congestive heart failure, diabetes, HIV/AIDS and human growth deficiencies. The company is a research and development company that develops technology that binds peptides to albumin in order to extend the half life of drugs from minutes to days. ConjuChem Biotechnologies is headquartered in Montréal , Canada. | Health Technology |
Lederle Laboratories
![]() Lederle Laboratories Miscellaneous Commercial ServicesCommercial Services Part of Pfizer Inc., Lederle Laboratories is a company that provides testing services. The company is based in Pearl River, NY. | Commercial Services |
Burroughs Wellcome | |
COR Therapeutics, Inc.
![]() COR Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology COR Therapeutics, Inc.. The principal activities of the Company are the discovery, development and commercialization of novel pharmaceutical products to establish new standards of care for the treatment and prevention of severe cardiovascular diseases. Integrilin was the Company's first product taken from discovery to commercialization. A drug was approved to treat patients who undergo a procedure known as angioplasty to open blood vessels. This drug has also been approved to treat patients with intermittent chest pains known as unstable angina and patients suffering from a kind of Heart attack known as non-Q-wave myocardial infraction | Health Technology |
Orphan Medical, Inc.
![]() Orphan Medical, Inc. Pharmaceuticals: MajorHealth Technology Orphan Medical, Inc. develops and markets pharmaceutical and health care products. The company was founded in 1993 and is located in Minnetonka, MN. | Health Technology |
ConjuChem Biotechnologies, Inc.
![]() ConjuChem Biotechnologies, Inc. Pharmaceuticals: MajorHealth Technology ConjuChem Biotechnologies, Inc. develops peptide based pharmaceuticals. Its peptide products are used to treat diseases such as congestive heart failure, diabetes, HIV/AIDS and human growth deficiencies. ConjuChem Biotechnologies is a research and development company that develops technology that binds peptides to albumin in order to extend the half life of drugs from minutes to days. The company was founded on August 25, 2009 and is headquartered in Montréal, Canada. | Health Technology |
Dennan Consulting | |
InVivo Therapeutics Corp.
![]() InVivo Therapeutics Corp. BiotechnologyHealth Technology InVivo Therapeutics Corp. operates as a medical device company that develops groundbreaking technologies for the treatment of spinal cord injuries. The company was founded by Joseph P. Vacanti and Robert S. Langer, Jr. in 2005 and is headquartered in Cambridge, MA. | Health Technology |
- Börse
- Insiders
- Mark D. Perrin
- Erfahrung